ScholarLens Back to search
2020•mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich)Requires access

Long-term efficacy and safety of eculizumab in aqp4+neuromyelitis optica spectrum disorder

Dean M. Wingerchuk, Achim Berthele, K Fujihara, Celia Oreja‐Guevara, H J Kim, Mónica Levy, Ichiro Nakashima, Jacqueline Palace, S. Shang, Marcus Yountz, Larisa Miller, S J Pittock

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Neuromyelitis optica, Eculizumab, Spectrum disorder, Medicine, Multiple sclerosis, Aquaporin 4, Term (time), Immunology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Long-term efficacy and safety of eculizumab in aqp4+neuromyelitis optica spectrum disorder — Research Paper | ScholarLens